iPS Cell Therapy for Parkinson’s Disease

DOI DOI Web Site Web Site PubMed 29 References Open Access
  • Takahashi Jun
    Center for iPS Cell Reserach and Application, Kyoto University Department of Neurosurgery, Kyoto University Graduate School of Medicine

Bibliographic Information

Other Title
  • iPS細胞を用いたパーキンソン病治療に向けて
  • iPS サイボウ オ モチイタ パーキンソンビョウ チリョウ ニ ムケテ
  • iPS Cell Therapy for Parkinson’s Disease

Search this article

Description

  The aim of stem cell therapy for Parkinson’s disease (PD) is to reconstruct local synapse formation and/or induce the release of dopamine and cytokines from grafted cells in the putamen. Fetal ventral-midbrain cells are reported to relieve the neurological symptoms of PD patients. However, induced pluripotent stem cells (iPSCs) are expected to provide an alternative donor cell population because of their capacity for self-renewal and pluripotency. A protocol to generate dopaminergic (DA) neurons from iPSCs has been developed, and human embryonic stem cells (ESCs) were proven to function in the brain of rat and monkey PD models. We have developed a method to isolate DA neuron progenitors as a donor cell population, which will enable us to perform trial demonstrating the allogenic transplantation of HLA-homozygous iPS cell-derived DA neurons for PD patients.

Journal

References(29)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top